文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

黄芩苷对脓毒症小鼠急性肾损伤的保护作用及机制

[Protective effect and mechanism of Baicalin on acute kidney injury in septic mice].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论脓毒症小鼠模型中,中、高剂量黄芩苷预处理可改善肾功能、减轻肾损伤并延长7天生存,机制可能与上调c-FLIP、抑制凋亡有关。

该研究将100只小鼠随机分为假手术组、盲肠结扎穿孔(CLP)脓毒症模型组及黄芩苷(BAI)低、中、高剂量预处理组(25、50、100 mg/kg,每日1次,连续3天,第3天给药后6小时行CLP)。中、高剂量BAI预处理组24小时肾功能指标(SCr、BUN、pNGAL、pKIM-1)较CLP组显著降低(均P<0.01),肾组织病理损伤减轻,肾小管上皮细胞凋亡减少,c-FLIP蛋白表达显著升高(均P<0.01)。7天平均生存时间呈剂量依赖性延长(低、中、高剂量组分别为3.5±2.5、5.4±2.2、5.9±1.9天 vs CLP组2.1±1.2天,P<0.001)。低剂量BAI预处理改善肾功能但不显著。

要点

  • 中、高剂量BAI预处理组24小时SCr(μmol/L)分别为135.16±5.18、125.70±5.26,均低于CLP组的170.42±5.42(P<0.01)。
  • 中、高剂量BAI预处理组7天平均生存时间(天)分别为5.4±2.2、5.9±1.9,长于CLP组的2.1±1.2(Log-Rank P<0.001)。
  • 低剂量BAI(25 mg/kg)预处理虽改善肾功能,但差异无统计学意义。
  • 中、高剂量BAI预处理组肾小管上皮细胞凋亡数(cells/HP)分别为16.20±0.49、13.10±0.66,低于CLP组的29.60±0.49(P<0.01)。
  • 中、高剂量BAI预处理组肾组织c-FLIP蛋白表达(c-FLIP/GAPDH)分别为0.35±0.02、0.46±0.02,高于CLP组的0.21±0.01(P<0.01)。

适用人群与场景

  • CLP诱导的脓毒症相关急性肾损伤(SA-AKI)小鼠模型;BAI为预处理给药(CLP前3天开始),非治疗性给药。

诊断标准与关键阈值

  • 原文未提及临床诊断标准或评分界值;动物模型采用盲肠结扎穿孔(CLP)复制脓毒症,假手术组仅开腹关腹、不结扎穿孔盲肠。

处置流程与药物剂量

  • 动物实验方案:BAI低、中、高剂量分别为25、50、100 mg/kg,每日给药1次、连续3天,第3天给药后6小时行CLP;原文未提及给药途径。
  • 对照:假手术组与CLP组给予等量蒸馏水。
  • 原文未提及临床用药剂量、途径、频次或目标值。

红旗征与不能漏的情况

  • 原文未提及临床红旗征或需立刻处理的情况。

研究设计与关键结果

  • 研究类型:动物实验;样本量100只小鼠,随机分为5组、每组20只(每组10只用于24小时取材、10只用于7天生存分析);单中心(原文未明确中心数)。
  • 干预与对照:BAI低、中、高剂量预处理组 vs CLP模型组 vs 假手术组。
  • 主要终点:24小时肾功能——中、高剂量BAI组SCr、BUN、pNGAL、pKIM-1均显著低于CLP组(均P<0.01);低剂量组差异无统计学意义。
  • 关键次要终点:肾组织病理损伤减轻、肾小管上皮细胞凋亡减少(P<0.01)、c-FLIP蛋白表达升高(P<0.01);7天平均生存时间呈剂量依赖性延长(P<0.001),假手术组7天内无死亡。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠CLP模型);原文未给出证据等级或推荐强度。
  • 局限:动物模型、预处理设计(非治疗性给药)、样本量有限(每组20只,终点分析每组10只)、单中心;结果不能直接外推至临床患者。

对床旁实践的改变

  • 该内容为动物实验,尚不能改变急诊/ICU对SA-AKI的临床实践;不适用于临床患者决策。
  • 原文未提供临床适用人群、禁忌人群或常见陷阱的相关信息。

指南或共识出处

  • 原文未提及指南或共识出处;来源期刊为Zhonghua Wei Zhong Bing Ji Jiu Yi Xue。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To observe the protective effect and mechanism of different doses of Baicalin (BAI) on acute kidney injury (AKI) in septic mice.

METHODS: According to the random number table, 100 mice were divided into sham operation group (Sham group), cecal ligation and perforation (CLP) induced sepsis model group (CLP group) and BAI pretreatment groups. The mice in BAI pretreatment groups were divided into low-, medium- and high-dose groups (BAI-L+CLP, BAI-M+CLP, BAI-H+CLP groups), with 20 mice in each group. A murine sepsis associated-acute kidney injury (SA-AKI) model was reproduced using CLP. The mice in the Sham group were only opened and closed the abdomen, without ligating or perforating the cecum. The mice in the BAI pretreatment groups were given BAI 25, 50 and 100 mg/kg daily for 3 days, and CLP was performed at 6 hours after administration of BAI at the 3rd day to reproduce sepsis model. The mice in the Sham group and CLP group were given the same amount of distilled water as control. Ten mice were sacrificed at 24 hours after operation to collect orbital blood for renal function determination [serum creatinine (SCr), blood urea nitrogen (BUN), plasma neutrophil gelatinase-associated lipocalin (pNGAL) and plasma kidney injury molecule-1 (pKIM-1)] by enzyme linked immunosorbent assay (ELISA). The kidney tissue was collected to observe the kidney tissue injury under light microscope after hematoxylin-eosin (HE) staining. The TdT-mediated dUTP nick-end labeling (TUNEL) was used to detect the apoptosis of renal tubular epithelial cells. Western blotting was used to detect the expression of cell FLICE like inhibitory protein (c-FLIP) in renal tissue. The remaining 10 mice in each group were used to calculate the survival rate of 7 days after operation.

RESULTS: The renal tubular epithelial cells in the CLP group were massively degenerated with necrosis, the renal tubular lumen was significantly expanded, and inflammatory cells were widely infiltrated in the renal interstitium. Furthermore, the renal function deteriorated rapidly. Compared with the CLP group, the renal function of mice pretreated with low dose of BAI was improved, but the difference was not significant. Compared with the CLP group, the renal function in the mice pretreated with medium and high doses of BAI was significantly improved, the SCr, BUN, pNGAL and pKIM-1 were significantly reduced [SCr (μmol/L): 135.16±5.18, 125.70±5.26 vs. 170.42±5.42; BUN (mmol/L): 33.59±1.77, 27.29±1.61 vs. 45.68±1.39; pNGAL (μg/L): 91.29±4.68, 73.40±3.77 vs. 131.50±6.55; pKIM-1 (μg/L): 6.34±0.30, 5.51±0.35 vs. 8.03±0.29; all P < 0.01], the pathological injury of renal tissue was significantly decreased, the apoptotic number of renal tubular epithelial cells was significantly reduced (cells/HP: 16.20±0.49, 13.10±0.66 vs. 29.60±0.49, both P < 0.01), and the expression of c-FLIP protein in renal tissue was significantly increased [c-FLIP protein (c-FLIP/GAPDH): 0.35±0.02, 0.46±0.02 vs. 0.21±0.01, both P < 0.01]. No mouse in the Sham group died within 7 days. Compared with the CLP group, the average survival time of the mice within 7 days in the BAI-L+CLP, BAI-M+CLP and BAI-H+CLP groups was significantly prolonged with a dose-dependent manner (days: 3.5±2.5, 5.4±2.2, 5.9±1.9 vs. 2.1±1.2; Log-Rank test: χ2 = 73.410, P < 0.001).

CONCLUSIONS: Pretreatment with medium and high doses of BAI can significantly improve the renal function in mice with SA-AKI, decrease the pathological damage and increase the survival of mice, and its mechanism may be related to promoting the increase of c-FLIP protein expression and inhibiting cell apoptosis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Le J, Fan H, Sun M, et al. [Protective effect and mechanism of Baicalin on acute kidney injury in septic mice]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34412759. doi:10.3760/cma.j.cn121430-20201204-00756

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。